S. 229In Committee

DTC Act of 2025

What this bill does

Requires certain prescription drug and biologic ads covered by Medicare or Medicaid to clearly disclose 30 day wholesale prices for consumers

Key points
  • Require wholesale price disclosures
  • Authorize civil penalties
  • Limit requirement to higher cost ads
  • Allow insurance cost explanation

Where it stands

Status
In Committee
Latest action
2025-01-23Read twice and referred to the Committee on Finance. (text: CR S337-338; Sponsor introductory remarks on measure: CR S337)

Topics and policy areas

Select a topic to continue exploring related legislation, members, and committees.

About these signals

Methodology

Impact and Momentum are relative discovery aids calculated by Legislation Lemur. They help you scan the congressional record; they are not predictions, endorsements, ideological ratings, or measures of policy importance.

Impact ScoreOverall observed legislative footprint and accumulated activity.
MomentumHow recently active or changing the bill appears in available data.